feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient",https://www.benzinga.com/general/biotech/20/07/16667306/the-daily-biotech-pulse-2-ipos-nabriva-pneumonia-drug-gets-canadian-regulatory-nod-phasebio-doses,https://j.mp/2OzA2mF
